Twist Bioscience (TWST) Inventory Average (2018 - 2025)

Twist Bioscience (TWST) has disclosed Inventory Average for 5 consecutive years, with $41.2 million as the latest value for Q3 2022.

  • On a quarterly basis, Inventory Average rose 55.27% to $41.2 million in Q3 2022 year-over-year; TTM through Sep 2022 was $41.2 million, a 55.27% increase, with the full-year FY2022 number at $35.6 million, up 61.28% from a year prior.
  • Inventory Average was $41.2 million for Q3 2022 at Twist Bioscience, up from $36.0 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $41.2 million in Q3 2022 to a low of $5.0 million in Q2 2019.
  • A 5-year average of $15.2 million and a median of $12.3 million in 2020 define the central range for Inventory Average.
  • Peak YoY movement for Inventory Average: grew 27.24% in 2019, then skyrocketed 180.33% in 2021.
  • Twist Bioscience's Inventory Average stood at $5.8 million in 2018, then increased by 27.24% to $7.4 million in 2019, then skyrocketed by 74.27% to $12.8 million in 2020, then surged by 180.33% to $36.0 million in 2021, then increased by 14.28% to $41.2 million in 2022.
  • Per Business Quant, the three most recent readings for TWST's Inventory Average are $41.2 million (Q3 2022), $36.0 million (Q4 2021), and $26.5 million (Q3 2021).